Inhaler Devices: The past, the Present, and the Future - European Medical Journal

This site is intended for healthcare professionals

Inhaler Devices: The past, the Present, and the Future

Respiratory
Download PDF
Chairperson:
Richard Dekhuijzen 1
Speakers:
Gary Wong , 2 J. Christian Virchow , 3 Henry Chrystyn 4-6
Acknowledgements:

Writing assistance was provided by Dr Sarah Utley, ApotheCom.

Keywords:
ERS Congress, European Respiratory Congress
Citation:
EMJ Respir. ;3[2]:49-54. DOI/10.33590/emjrespir/10314624. https://doi.org/10.33590/emjrespir/10314624.
Support:

The publication of this article was funded by Teva Pharmaceuticals. The views and opinions expressed are those of the authors and not necessarily of Teva Pharmaceuticals.

Each article is made available under the terms of the Creative Commons Attribution-Non Commercial 4.0 License.

Meeting Summary

Inhaler handling errors negatively impact asthma control and represent one of the most common challenges in asthma management. Overcoming inhaler handling errors can be achieved by increased awareness of errors, more explicit and consistent training in inhaler use, and development of ‘intuitive’ devices. Clinical studies have shown that dry powder inhalers (DPIs) have better dose consistency and delivery to the lungs, but this is also dependent on device and inhalation technique. In addition, recent clinical studies have demonstrated that Spiromax® is a more intuitive device than Turbuhaler®. In studies analysing patient device mastery, intuitive devices are preferred by patients because they are easy/simple to use and have effective dose delivery.

Please view the full content in the pdf above.

Rate this content's potential impact on patient outcomes

Average rating / 5. Vote count:

No votes so far! Be the first to rate this content.